Clinical isolates of the Bacteroides melaninogenicus and Bacteroides fragilis groups were tested for in vitro and in vivo susceptibility to penicillin, clindamycin, and metronidazole, used singly or in combination with gentamicin. The in vitro tests consisted of determinations of minimal inhibitory concentrations (MICs) carried out with or without constant amounts of gentamicin. When used alone, gentamicin had negligible effects on the bacteria but significantly reduced the MICs of penicillin, clindamycin, and metronidazole against 11, 10, and 3, of the 15 strains of the B. melaninogenicus group, respectively. The 15 strains of the B. fragilis group were all P-lactamase producers and were highly resistant to penicillin or the combination of penicillin and gentamicin. However, gentamicin reduced the MICs of clindamycin and metronidazole against 1 and 7 strains of this group, respectively. The in vivo tests were carried out in mice and consisted of measurements of the effects of the antimicrobial agents on the sizes and bacterial content of abscesses induced by subcutaneous injection of bacterial suspensions. This work was prompted by the need to extend the abovedescribed observations on drug synergism to other antibacterial combinations and to strains of the B. melaninogenicus group. We show that, with many strains, gentamicin, which by itself has a negligible inhibitory effect on Bacteroides spp., is very effective in combination with penicillin, clindamycin, or metronidazole in reducing the minimal inhibitory concentrations (MICs) of these antimicrobial agents and in suppressing abscess formation in infected mice.
Anaerobic bacteria of the Bacteroides fragilis and Bacteroides melaninogenicus groups are important clinical pathogens, B. fragilis in intra-abdominal abscesses (2, 7) , B. melaninogenicus in lung and upper respiratory infections (1) . Since Bacteroides spp. are often recovered from mixed infections with aerobic bacteria, penicillin or a cephalosporin is commonly administered for the treatment of infections due to B. melaninogenicus group bacteria, and chloramphenicol, cefoxitin, clindamycin, or metronidazole is given for B. fragilis group infections. When enteric gram-negative organisms are suspected in addition to anaerobes, aminoglycosides are also administered.
A number of investigators have been concerned with the possibility of antagonism between antibiotics, which, fortunately, has not been encountered with drugs used against Bacteroides spp. (4, 5, 10, 16) . A by-product of these studies has been the discovery that some antibiotics act synergistically against B. fragilis. For example, Fass et al. (5) reported in vitro synergism between clindamycin and the aminoglycoside gentamicin. These results were confirmed by Okubadejo and Allen (16) , who found this combination to be more effective than clindamycin combined with kanamycin. Busch et al. (4) obtained a significant synergistic effect between clindamycin and the antimicrobial agent metronidazole in 13 of 17 strains. Ralph and Amatnieks (18) tested six drugs in combination with metronidazole and found that nalidixic acid, clindamycin, and rifampin had a synergistic effect on some strains. Thadepalli et al. (20) obtained excellent synergistic activity between cefuroxime and penicillin or carbenicillin in two of three strains.
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This work was prompted by the need to extend the abovedescribed observations on drug synergism to other antibacterial combinations and to strains of the B. melaninogenicus group. We show that, with many strains, gentamicin, which by itself has a negligible inhibitory effect on Bacteroides spp., is very effective in combination with penicillin, clindamycin, or metronidazole in reducing the minimal inhibitory concentrations (MICs) of these antimicrobial agents and in suppressing abscess formation in infected mice.
(The experiments conducted herein were carried out in accordance with the principles set forth in the Guide for the Care and Use of Laboratory Animals, Institutes of Laboratory Resources, National Research Council, Department of Health, Education, and Welfare publication no. NIH 74-23.)
MATERIALS AND METHODS
Bacteria. All Bacteroides strains were recent isolates from clinical specimens obtained from the Children's Hospital, Washington, D.C. or from the Naval Medical Command, National Capital Region, Bethesda, Md. They were identified in this laboratory by standard procedures (8, 19) . Of 15 isolates of the B. melaninogenicus group, 7 were Bacteroides intermedius, 4 were Bacteroides asaccharolyticus, and 4 were B. melaninogenicus. Of 15 isolates of the B. fragilis group, 6 were B. fragilis and 3 each were Bacteroides vulgatus, Bacteroides ovatus, and Bacteroides thetaiotaomicron (see Tables 1 and 2 ). All strains were encapsulated as confirmed by the Hiss staining method (14) and by electron microscopy after staining with ruthenium red (9) . Stock suspensions were stored in skim milk at -70°C. For the experiments described here, the bacteria were grown anaer-obically on blood agar plates with a brain heart infusion base (Difco Laboratories, Detroit, Mich.) for a total of two or three passages after isolation.
Animals fragilis group. For clindamycin, metronidazole, and gentamicin, twofold dilutions were used from 10 to 0.04, 50 to 0.1, and 200 to 0.8 ,ug/ml, respectively. The in vitro synergistic effect of gentamicin was determined by adding 10 pLg of gentamicin per ml to each dilution of the antimicrobial agent to be tested. The effect was considered synergistic if it reduced the MIC of the associated antibacterial agent by fourfold or more.
,-Lactamase activity was determined for all microorganisms by use of a chromogenic cephalosporin substrate (15) .
Infection of mice and antimicrobial therapy. Experiments usually consisted of 150 to 200 animals tested simultaneously, with 6 mice per experimental group, except 10 mice were used for determination of the levels of antimicrobial agents in serum and in abscesses. Mice were infected by subcutaneous injection into the right groin of 0.1-ml volumes of suspensions in saline containing 109 bacteria per ml. The antimicrobial agents, used singly or mixed with gentamicin, were administered intramuscularly on alternate thighs 2 h after inoculation and at 8-h intervals for 7 days. The amounts administered, in terms of a 20-g mouse per injection, were as follows: penicillin G, 0.67 mg; clindamicin, 0.27 mg; metronidazole, 0.33 mg; and gentamicin, 0.05 mg.
The mice were sacrificed on day 7 by cervical dislocation. The sizes of the abscesses were estimated from measurements by caliper of two perpendicular diameters, corresponding to maximum length and width. The product of these two measurements, expressed as millimeters squared, was approximately proportional to the outer surface of the abscess. For the determination of the bacterial contents of the abscesses, the abscess material was removed aseptically and homogenized in an anaerobic glove box in 1 ml of sterile saline in a ground glass tissue homogenizer. Tenfold serial dilutions of the homogenates were made in sterile saline, and 0.1-ml volumes of each dilution was spread in triplicate on brain heart infusion-enriched blood agar plates. No attempt was made to inactivate the antimicrobial agents in the homogenized abscess material, since a considerable dilution was achieved before plating, especially with the smaller abscesses. Colonies were counted after incubation at 37°C in an anaerobic chamber for 48 h, and the results are presented as log1o of viable bacteria per abscess.
In vivo synergism was defined as a significant reduction (P < 0.01) in abscess size associated with addition of gentamicin to the other antimicrobial agent. Statistical analyses were accomplished with the Student t test of independent means.
The levels of the antimicrobial agents in sera and abscesses were determined in a separate group of mice by the following methods: penicillin G and clindamycin, agar diffusion assay (12) with Micrococcus luteus ATCC 9341 (American Type Culture Collection, Rockville, Md.); metronidazole, high-pressure chromatography (21) ; gentamicin, agar diffusion assay with Bacillus subtilis ATCC 6051.
RESULTS
In vitro susceptibility of Bacteroides strains. Table 1 shows the MICs of 15 isolates of the B. melaninogenicus group with respect to three antimicrobial agents tested alone or in combination with 10 ,ug of gentamicin per ml. Although none of the isolates produced P-lactamase, susceptibility to penicillin varied greatly, requiring MICs ranging from 0.01 to 6 ,ug/ml. The MICs for 5 of 6 strains requiring high MICs and several requiring moderate MICs, a total of 11, were significantly reduced by gentamicin. Susceptibility to clindamycin varied somewhat less, with MICs ranging from 0.31 to 2.5 ,ug/ml. Ten of these MICs were reduced by gentamicin. With metronidazole, the MICs were close to the lower concentrations used in the test, 0.2 to 1.6 j±g/ml, and the MICs of only three strains were reduced by gentamicin. It is possible, however, that the concentrations used were not sufficiently low to detect all possible instances of synergism with strains of the B. melaninogenicus and B. fragilis groups. Gentamicin by itself had little if any inhibitory effect on strains of either group (Tables 1 and 2 ).
All 15 strains of the B. fragilis group were ,-lactamase producers and highly resistant to penicillin (MICs, >64
,ug/ml) in the presence or absence of gentamicin (data not shown). The MICs of clindamycin and metronidazole alone and in combination with gentamicin are shown in Table 2 . The MIC of clindamycin ranged from 0.15 to 2.5 ,ug/ml, but the MIC was reduced by gentamicin for only one strain, from 0.15 to 0.04 ,ug/ml. The MIC of metronidazole ranged from 0.2 to 6.25 ,ug/ml. The MICs for seven strains were reduced to a moderate extent by gentamicin.
In vivo effect of combined antimicrobial therapy. The 30 isolates used in these studies reproducibly elicited abscesses when injected into the groins of mice. Since these strains were encapsulated, no virulence-enhancing factor was required (9) . The sizes of these abscesses (see Tables 3 and 4) are measurements of outer surfaces, as described in Materials and Methods. This type of measurement was used in preference to volume because the thickness of the abscesses could not be estimated with accuracy and the abscesses were not firm enough to be dissected out and weighed. Without antimicrobial therapy, the abscesses achieved a mean outer surface size of about 300 mm2, with relatively small differences among the strains.
The effects of antimicrobial therapy on abscess formation of isolates of the B. melaninogenicus group are shown in Table 3 . The abscesses induced by 12 of 15 strains were reduced to a significant but relatively moderate extent by penicillin. A substantial further reduction was achieved with a combination of penicillin and gentamicin with these 12 strains and with one which had not been affected by penicillin administered singly. The results (Table 3) agreed reasonably well from those expected from MIC determinations (Table 1 ). An unexplained discrepancy is the low MICs of penicillin for strain 8 of B. asaccharolyticus and the lack of in vivo efficacy. Clindamycin greatly reduced the sizes of all abscesses, and an even greater reduction was achieved with nine strains when the drug was combined with gentamicin. These results are in good agreement with those shown in Table 1 . Metronidazole proved to be efficacious against all Gentamicin administered by itself did not result in a reduction in the sizes of the abscesses, but surprisingly, in some cases elicited a significant increase.
As expected, none of the abscesses elicited by the 15 strains of the B. fragilis group were affected by penicillin or a combination of penicillin and gentamicin (data not shown). Similarly, gentamicin was without effect, except that it elicited an increase in the sizes of abscesses induced by one strain ( Table 4) . As expected from the data shown in Table 2 , clindamycin and metronidazole were efficacious against all strains, but synergism with gentamicin was not clearly demonstrated in vivo.
The viable counts of the abscesses described in Tables 3  and 4 a The mice were infected and treated as described in Materials and Methods. The abscess sizes, determined on day 7 postinfection, are expressed as the products of two surface dimensions (millimeters squared) and are presented as the means ± standard deviations of six mice in each group. -, Without gentamicin; +, with gentamicin (7.5 mg/kg per day).
b Significant reduction (P < Q.01) of abscess size by a single antimicrobial agent (without gentamicin). c Significant synergistic effect (P < 0.01) with gentamicin. ity that in some cases it may have enhanced them cannot be excluded.
With strains of the B. fragilis group (Table 6 ), the number of CFU in the abscesses of untreated mice were also relatively uniform, from 1086 to 10108, and the counts in the gentamicin-treated mice were approximately the same. Clindamycin had a variable effect on the number of CFU, reducing them by about 2 to 8 logs. A further reduction by this drug in combination with gentamicin is not apparent. The reduction achieved by metronidazole was somewhat higher, from about 3 to 9.5 logs. In combination with gentamicin, metronidazole significantly reduced the number of CFU in only one instance (B. fragilis 13). The abscesses elicited by this strain and this drug combination were also reduced to a small but not highly significant extent (Table 4) .
The concentrations of the antimicrobial agents in sera and in the abscesses of mice were checked with only two strains (B. asaccharolyticus 114 and B. fragilis 13) and only on day 7 after infection (Table 7) . It is obvious that sufficient levels were achieved in both locations to inhibit the susceptible strains. It is interesting to note that the penicillin concentrations in the abscesses were considerably lower in mice infected with the B. fragilis strains than in those infected with B. asaccharolyticus, possibly because the B. fragilis strains but not the B. asaccharolyticus strains contained 1B-lactamase which destroyed penicillin.
DISCUSSION
In this study, 30 strains of Bacteroides spp. were tested for their susceptibilities to four antimicrobial agents plus three antimicrobial agent combinations by three criteria: MIC, reduction in sizes of abscesses elicited in mice, and bacterial content in these abscesses. Often, but not always, low MICs correlated well with small abscess sizes and low bacterial contents. Some of the more obvious discrepancies have already been noted. In other cases, although the general trend was the same, there were large differences in the bacterial content of abscesses of approximately equal size (compare, for example, the effect of clindamycin in Tables 4  and 6 ). These discrepancies and qualitative differences may in some cases be due to imperfections of the animal model and methodology used. However, the mice appeared to have tolerated well the multiple injections of the antimicrobial agents, and our limited test of antimicrobial agent content in sera and abscesses indicated that the dosage was adequate. Undoubtedly, unrecognized variations in the physiological properties of the strains played an important role. Thus, both in vitro and in vivo results must be taken into consideration before any conclusions are derived from this study.
Previous investigations of the effect on Bacteroides spp. of antibiotics and antibiotic combinations were primarily concerned with B. fragilis (4-6, 10-13, 16, 18, 20, 22 ). There is general agreement that gentamicin by itself is relatively ineffective (6) . The exacerbation of some of the abscesses seen in this study was possibly due to interference with the defense mechanism of the hosts (unpublished observations).
Metronidazole has been recognized as one of the most effective antimicrobial agents, consistently inhibitory and bactericidal at achievable in vivo concentrations (22) . Because of this finding, this agent has been most frequently studied in combination with other antibiotics, such as clindamycin (4, 18) and spiramycin (11) , which proved to be synergistic. The combination of clindamycin and gentamicin has been found to be synergistic by some (5, 16) but not by all investigators (10) . 
